Chirosynkem Laboratories Private Limited
About Chirosynkem Laboratories Private Limited
Data last updated:
Chirosynkem Laboratories Private Limited is a private limited company based in Medipally, Telangana, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 22 September 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2021PTC155155.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Satish Kumar Rangaraju and Mergu Naveen.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No 301 Vr Residency P&T Colony Street No.2 Near Kakatiya Hospital, Medipally, Telangana, India – 500098.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.51 Cr, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹1.7 Lakh (net margin 0.7%) and EBITDA of ₹4.32 Lakh (EBITDA margin 1.7%). Revenue has grown at a compounded annual rate (CAGR) of 258% over three years.
Company details
Contact details
Chirosynkem Laboratories Private Limited's registered office is in Medipally, Telangana.
- Registered AddressFlat No 301 Vr Residency P&T Colony Street No.2 Near Kakatiya Hospital, Medipally, Telangana, India – 500098
- IndustryChemicals, Manufacturing, Basic Chemical
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Chirosynkem Laboratories is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Chirosynkem Laboratories Private Limited, buy the company report.
Financials of Chirosynkem Laboratories Private Limited
FY 2025 filings availableChirosynkem Laboratories Private Limited reported revenue of ₹2.51 Cr (up 22% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 258% over three years, including 22% growth in the latest year. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹4.32 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹1.7 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.7% | |||
| Net Profit Margin | 0.7% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Chirosynkem Laboratories Private Limited, buy the company report.
Board of directors of Chirosynkem Laboratories Private Limited
Chirosynkem Laboratories has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satish Kumar Rangaraju Also directs: Astinova Bio Labs Private Limited | Director | 22 Sep 2021 | 5 Years 1 Months | Current |
| Mergu Naveen | Director | 22 Sep 2021 | 5 Years 1 Months | Current |
| Mounika Chevva | Director | 22 Sep 2021 | 5 Years 1 Months | Current |
| Seetharama Naidu Neerasa | Director | 03 May 2023 | 3 Years 5 Months | Current |
Peer comparison
Chirosynkem Laboratories Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Eviza Biotech Private Limited | ₹2.51 Cr (FY 2025) | -1.0% | Chandigarh, India | |||
| Viprav Ventures India Private Limited | ₹2.51 Cr (FY 2025) | 41.0% | Raipur, Chhattisgarh, India | |||
| Astami Marketing Private Limited | ₹2.51 Cr (FY 2016) | 145.0% | Kolkata, West Bengal, India | |||
| KSR Chemicals and Fortune Trading Private Limited | ₹2.51 Cr (FY 2018) | 975.0% | Chennai, Tamil Nadu, India | |||
| Durfi Retail Private Limited | ₹2.51 Cr (FY 2024) | -7.0% | New Delhi, Delhi, India | |||
| Chirosynkem Laboratories Private Limitedthis company | ₹2.51 Cr (FY 2025) | ₹1.7 Lakh | 0.7% | 22.0% | Medipally, Telangana, India | |
| Pioneers Office Solutions Private Limited | ₹2.51 Cr (FY 2020) | 20.0% | Bangalore, Karnataka, India | |||
| Umasons Pharma Private Limited | ₹2.51 Cr (FY 2016) | -20.0% | Jaipur, Rajasthan, India | |||
| Acario Enterprises Private Limited | ₹2.51 Cr (FY 2024) | -15.0% | Patna, Bihar, India | |||
| Olleracomp IT Services Private Limited | ₹2.51 Cr (FY 2025) | -36.0% | Delhi, India | |||
| Zvention Media Private Limited | ₹2.51 Cr (FY 2024) | -61.0% | New Delhi, Delhi, India |
To see the full peer comparison of Chirosynkem Laboratories Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Chirosynkem Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Chirosynkem Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Chirosynkem Laboratories Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Chirosynkem Laboratories Private Limited has 5 board changes on record since 2021: 4 appointments and 1 cessation. The latest: Seetharama Naidu Neerasa ceased to be Additional Director on 29 Sep 2023.
Frequently asked questions
Chirosynkem Laboratories is an active private limited company based in Medipally, Telangana, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 22 September 2021 (5+ years old) and is registered under CIN U24100TG2021PTC155155.
Chirosynkem Laboratories has 4 current directors:
- Satish Kumar Rangaraju - Director
- Mergu Naveen - Director
- Mounika Chevva - Director
- Seetharama Naidu Neerasa - Director
The latest financial statements of Chirosynkem Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Chirosynkem Laboratories is U24100TG2021PTC155155. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Chirosynkem Laboratories was incorporated on 22 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Chirosynkem Laboratories by revenue are Eviza Biotech Private Limited, Viprav Ventures India Private Limited, Astami Marketing Private Limited, KSR Chemicals and Fortune Trading Private Limited, Durfi Retail Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Seetharama Naidu Neerasa ceased to be Additional Director on 29 Sep 2023. Seetharama Naidu Neerasa was appointed as Director on 03 May 2023. Mergu Naveen was appointed as Director on 22 Sep 2021. Chirosynkem Laboratories has 5 board changes on record in total.
The registered office of Chirosynkem Laboratories is at Flat No 301 Vr Residency P&T Colony Street No.2 Near Kakatiya Hospital, Medipally, Telangana, India – 500098.
Chirosynkem Laboratories operates in the chemicals industry, in the manufacturing segment.
Chirosynkem Laboratories can be reached at its registered office: Flat No 301 Vr Residency P&T Colony Street No.2 Near Kakatiya Hospital, Medipally, Telangana, India – 500098.
Chirosynkem Laboratories is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
